Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
International Urology and Nephrology
Erschienen in: International Urology and Nephrology 3/2009

01.09.2009 | Nephrology - Review

Home dialysis as a first option: a new paradigm

verfasst von: Dimitrios G. Oreopoulos, Elias Thodis, Ploumis Passadakis, Vassilis Vargemezis

Erschienen in: International Urology and Nephrology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Traditionally, the initial choice of dialysis for patients with end stage renal disease (ESRD) has been in-center hemodialysis (HD) or peritoneal dialysis (PD). Usually, the choice between these (PD vs. HD) has been based on the characteristics of the dialysis techniques. Obviously the choice of peritoneal dialysis implied dialysis at home, but its geographic location has been only a secondary consideration. Peritoneal dialysis has evolved as a dependable mode that gives good outcomes. This method has become more attractive with the option of overnight cyclers and the recent use of home helpers in some jurisdictions. At the same time the interest in home hemodialysis was rekindled by reports of good outcomes with short daily or nocturnal hemodialysis. Home dialysis (PD or HD) offers high quality of treatment, a high degree of patient independence, and is financially attractive. Therefore, we propose a change in our approach to the choice of the initial form of dialysis for patients with ESRD. Instead of choosing between HD and PD we should present the new patients the advantage of dialysis at home and instead of asking them to choose between peritoneal dialysis or hemodialysis, they should be offered the option to choose between dialysis at home (PD or HD) or in-hospital. This paper will review the advantages of the home-based dialysis methods and the arguments for this simple but vital change in the process of choosing the method of dialysis.
Literatur
1.
2.
3.
Verger C, Duman M et al (2007) Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French language peritoneal dialysis registry. Nephrol Dial Transplant 22(4):1218–1223. doi:10.​1093/​ndt/​gfl760 PubMedCrossRef
4.
5.
Mehrotra R, Marsh D et al (2005) Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 68(1):378–390PubMed
6.
7.
Van Biesen W, Vanholder R et al (2000) The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 20(4):375–383PubMed
8.
Lameire N, Van Biesen W et al (2000) The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 20(Suppl 2):S134–S141PubMed
9.
10.
The United Kingdom Renal Registry (2002) 5th Annual report
11.
12.
Jung B, Blake PG et al (1999) Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int 19(3):263–268PubMed
13.
14.
Termorshuizen F, Korevaar JC et al (2003) Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands cooperative study on the adequacy of dialysis 2. J Am Soc Nephrol 14(11):2851–2860. doi:10.​1097/​01.​ASN.​0000091585.​45723.​9E PubMedCrossRef
15.
16.
Bloembergen WE, Port FK et al (1995) A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6(2):177–183PubMed
17.
CORR Report (2002, 2003) Treatment of end stage organ failure in Canada, 2002 and 2003. p 9
18.
Gokal R, Figueras M et al (1999) Outcomes in peritoneal dialysis and haemodialysis—a comparative assessment of survival and quality of life. Nephrol Dial Transplant 14(Suppl 6):24–30PubMedCrossRef
19.
Held PJ, Port FK et al (1994) Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 45(4):1163–1169PubMedCrossRef
20.
Fox JG, Fowler I et al (1993) Audit of a decade of continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 8(3):240–243PubMed
21.
Maiorca R, Cancarini GC et al (1996) Differing dialysis treatment strategies and outcome. Nephrol Dial Transplant 11(Suppl 2):134–139PubMed
22.
Maitra S, Sekercioglu N et al (2007) Causes of death in older peritoneal dialysis patients—can we depend on registry reports? Int Urol Nephrol 39(1):345–350PubMedCrossRef
23.
Coles GA, Williams JD (1998) What is the place of peritoneal dialysis in the integrated treatment of renal failure? Kidney Int 54(6):2234–2240PubMedCrossRef
24.
Keshaviah P, Collins AJ et al (2002) Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol 13(Suppl 1):S48–S52PubMed
25.
US Renal Data System (USRDS) (2007) Annual data report: Atlas of end-stage renal disease in the United States patient survival
26.
Tanna MM, Vonesh EF et al (2000) Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting. Am J Kidney Dis 36(6):1175–1182PubMedCrossRef
27.
Davies SJ, Phillips L et al (1998) What really happens to people on long-term peritoneal dialysis? Kidney Int 54(6):2207–2217PubMedCrossRef
28.
Lysaght MJ (1996) Preservation of residual renal function in maintenance dialysis patients. Perit Dial Int 16(2):126–127PubMed
29.
Berlanga JR, Marron B et al (2002) Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 22(2):239–242PubMed
30.
Degoulet P, Legrain M et al (1982) Mortality risk factors in patients treated by chronic hemodialysis. Report of the diaphane collaborative study. Nephron 31(2):103–110PubMedCrossRef
31.
Leavey SF, Strawderman RL et al (1998) Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31(6):997–1006PubMedCrossRef
32.
Aslam N, Bernardini J et al (2002) Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 22(2):191–196PubMed
33.
Pliakogiannis T, Trpeski L et al (2007) Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature. Int Urol Nephrol 39(1):281–288PubMedCrossRef
34.
(1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada–USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 7(2):198–207
35.
Hakim RM, Lowrie E (1999) Obesity and mortality in ESRD: is it good to be fat? Kidney Int 55(4):1580–1581PubMedCrossRef
36.
McCusker FX, Teehan BP et al (1996) How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada–USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int Suppl 56:S56–S61
37.
Ramkumar N, Pappas LM et al (2005) Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int 25(5):461–469PubMed
38.
Fried L, Bernardini J et al (1996) Neither size nor weight predicts survival in peritoneal dialysis patients. Perit Dial Int 16(4):357–361PubMed
39.
Just PM, de Charro FT et al (2008) Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 23(7):2365–2373PubMedCrossRef
40.
Baboolal K, McEwan P et al (2008) The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant 23(6):1982–1989PubMedCrossRef
41.
De Vecchi AF, Dratwa M et al (1999) Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 14(Suppl 6):31–41PubMedCrossRef
42.
Shih YC, Guo A et al (2005) Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 68(1):319–329PubMedCrossRef
43.
Salonen T, Reina T et al (2007) Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis. Int Urol Nephrol 39(1):289–298PubMedCrossRef
44.
45.
46.
Goeree R, Manalich J et al (1995) Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 18(6):455–464PubMed
47.
Wolcott DL, Nissenson AR (1988) Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Am J Kidney Dis 11(5):402–412PubMed
48.
Bremer BA, McCauley CR et al (1989) Quality of life in end-stage renal disease: a reexamination. Am J Kidney Dis 13(3):200–209PubMed
49.
Simmons RG, Anderson CR et al (1990) Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl 131:7–22PubMed
50.
Auer J, Gokal R et al (1990) The Oxford–Manchester study of dialysis patients. Age, risk factors and treatment method in relation to quality of life. Scand J Urol Nephrol Suppl 131:31–37
51.
Tucker CM, Ziller RC et al (1991) Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Perit Dial Int 11(4):341–346PubMed
52.
Apostolou T (2007) Quality of life in the elderly patients on dialysis. Int Urol Nephrol 39(2):679–683PubMedCrossRef
53.
Ronco C, La Greca G (1997) Integration of peritoneal dialysis in active uremia treatment. Perit Dial Int 17(Suppl 2):S155–S160PubMed
54.
Julius M, Kneisley JD et al (1989) A comparison of employment rates of patients treated with continuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan End-Stage Renal Disease Study). Arch Intern Med 149(4):839–842PubMedCrossRef
55.
Merkus MP, Jager KJ et al (1997) Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 29(4):584–592PubMedCrossRef
56.
Woods JD, Port FK et al (1996) Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 49(5):1464–1470PubMedCrossRef
57.
Wu AW, Fink NE et al (2004) Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J Am Soc Nephrol 15(3):743–753PubMedCrossRef
58.
Bleyer AJ, Burkart JM et al (1999) Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 10(1):154–159PubMed
59.
Van Loo A, Heering P, Vanholder R, Grabensee B, Van Biesen W, Hesse U, Lameire N (1998) Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared to haemodialysis. Nephrol Dial Transplant 13:831 abstract
60.
Cancarini GC, Sandrini S et al (2006) Transplantation outcome in patients on PD and HD. Contrib Nephrol 150:259–270PubMedCrossRef
61.
Chalem Y, Ryckelynck JP et al (2005) Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France. Kidney Int 67(6):2448–2453PubMedCrossRef
62.
Helal I, Abderrahim E et al (2007) Impact of dialysis modality on posttransplantation results in kidney transplantation. Transplant Proc 39(8):2547–2549PubMedCrossRef
63.
Suri RS, Nesrallah GE et al (2006) Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 1(1):33–42PubMedCrossRef
64.
(2003) USRDS: The United States Renal Data System. Am J Kidney Dis 42(6 Suppl 5):1–230
65.
Eknoyan G, Beck GJ et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010–2019PubMedCrossRef
66.
Paniagua R, Amato D et al (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13(5):1307–1320PubMed
67.
Kjellstrand CM, Evans RL et al. (1975) The “unphysiology” of dialysis: a major cause of dialysis side effects? Kidney Int Suppl(2):30–4
68.
Grzegorzewska AE, Banachowicz W (2008) Evaluation of hemodialysis adequacy using online Kt/V and single-pool variable-volume urea Kt/V. Int Urol Nephrol 40(3):771–778PubMedCrossRef
69.
Nesrallah G, Suri R et al (2003) Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 42(1 Suppl):13–17PubMedCrossRef
70.
Woods JD, Port FK et al (1999) Clinical and biochemical correlates of starting “daily” hemodialysis. Kidney Int 55(6):2467–2476PubMedCrossRef
71.
Chan CT, Harvey PJ et al (2003) Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 42(5):925–931PubMedCrossRef
72.
Foley RN, Parfrey PS et al (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5(12):2024–2031PubMed
73.
London GM, Pannier B et al (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12(12):2759–2767PubMed
74.
Turkmen F, Emre A et al (2008) Relationship between aortic valve sclerosis and left ventricular hypertrophy in chronic haemodialysis patients. Int Urol Nephrol 40(2):497–502PubMedCrossRef
75.
Chan C, Floras JS et al (2002) Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 17(8):1518–1521PubMedCrossRef
76.
Lindsay RM, Alhejaili F et al (2003) Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42(1 Suppl):24–29PubMedCrossRef
77.
Al-Hejaili F, Kortas C et al (2003) Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 14(9):2322–2328PubMedCrossRef
78.
Heidenheim AP, Muirhead N et al (2003) Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 42(1 Suppl):36–41PubMedCrossRef
79.
Ting GO, Kjellstrand C et al (2003) Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 42(5):1020–1035PubMed
80.
Fong E, Bargman JM et al (2007) Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis. Clin J Am Soc Nephrol 2(6):1195–1200PubMedCrossRef
81.
Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA et al (1999) Clinical and biochemical correlates of starting “daily”hemodialysis. Kidney Int 55:2467–2476PubMedCrossRef
82.
83.
Kjellstrand CM, Buoncristiani U et al (2008) Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 23(10):3283–3289PubMedCrossRef
84.
Blagg CR (2003) Quotidian dialysis: The London, Ontario experience. Am J Kidney Dis 42(1 Suppl):1–2PubMedCrossRef
85.
Culleton BF, Walsh M et al (2007) Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298(11):1291–1299PubMedCrossRef
86.
Mohr PE, Neumann PJ et al (2001) The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 37(4):777–789PubMedCrossRef
87.
McFarlane PA, Bayoumi AM et al (2006) The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int 69(5):798–805PubMedCrossRef
88.
Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson D (2002) Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 40(3):611–622PubMedCrossRef
89.
Veger C et al (2007) Influence of autonomy and the type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients: an analysis of data from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant 22:1218–1223CrossRef
90.
Quinn RR, Oliver MJ (2006) Is assisted peritoneal dialysis an alternative to in-center hemodialysis? Perit Dial Int 26(6):650–653PubMed
91.
Inaguma D, Tatematsu M et al (2006) Effect of an educational program on the predialysis period for patients with chronic renal failure. Clin Exp Nephrol 10(4):274–278PubMedCrossRef
92.
Taskapan H, Tam P et al (2008) Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic. Int Urol Nephrol 40(3):841–848PubMedCrossRef
93.
Ifudu O, Dawood M et al (1996) Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 28(6):841–845PubMedCrossRef
94.
Innes A, Rowe PA et al (1992) Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant 7(6):467–471PubMed
95.
Roderick P, Jones C et al (2002) Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant 17(7):1252–1259PubMedCrossRef
96.
Stevenson KB, Hannah EL et al (2002) Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39(3):549–555PubMedCrossRef
97.
Blake PG (1999) Factors affecting international utilization of peritoneal dialysis: implications for increasing utilization in the United States. Semin Dial 12:365–369CrossRef
98.
Schmidt RJ, Domico JR et al (1998) Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 32(2):278–283PubMedCrossRef
99.
Tzamaloukas AH, Konstantinov KN et al (2008) Twenty-first Century ethics of medical research involving human subjects: achievements and challenges. Int Urol Nephrol 40(1):153–163PubMedCrossRef
Metadaten
Titel
Home dialysis as a first option: a new paradigm
verfasst von
Dimitrios G. Oreopoulos
Elias Thodis
Ploumis Passadakis
Vassilis Vargemezis
Publikationsdatum
01.09.2009
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2009
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9575-4

Weitere Artikel der Ausgabe 3/2009

International Urology and Nephrology 3/2009 Zur Ausgabe

Urology - Original Paper

Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy

Urology - Original Paper

Effect of intralesional verapamil for treatment of Peyronie’s disease: a randomized single-blind, placebo-controlled study

Nephrology - Case Report

Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?

Nephrology - Original Paper

Performance of the Cockcroft-Gault and MDRD equations in adult Nigerians with chronic kidney disease

Urology - Case Report

Penis covering and simultaneous urethral replacement by scrotal skin for severe penile and urethral necrosis

Urology - Original Paper

Bilateral adrenal tumor: causes and clinical features in eighteen cases

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise